OBJECTIVE:Vasomotor symptoms (VMS)(hot flashes, night sweats) are associated with natural or surgically or chemotherapy-induced menopause, the latter occurring frequently in women treated for breast cancer. To manage VMS, some women seek alternatives to menopausal hormone therapy, such as supplements or modified food choices. The objective of the present analyses was to assess associations of VMS occurrence and change in severity of VMS over 12 months with dietary intakes of fiber, fat, and selected soy-containing foods, and use of phytoestrogen or vitamin E supplements in women with recent early stage breast cancer, adjusting for covariates. DESIGN: Using multivariate logistic regression, data were analyzed from 2,198 women with early-stage breast cancer who enrolled 2 to 48 months after diagnosis in the Women's Healthy Eating and Living randomized, controlled trial of a high-vegetable, high-fiber, reduced-fat diet. RESULTS: Being peri- or postmenopausal, using tamoxifen, having low social support or depressive symptoms, and using vitamin E or phytoestrogen supplements were significantly associated cross-sectionally with reporting moderate/severe VMS at enrollment. Increased symptom severity after 12 months was significantly associated with higher body mass index, tamoxifen use, and smoking. Decreased symptom severity at 12 months was significantly associated with high dietary fiber intake; no decrease was observed in women who were peri- or postmenopausal, using tamoxifen, or had low fat intake or low social support. CONCLUSIONS: High dietary fiber intakes, premenopausal, and high social support were related to decreased severity of VMS 1 year after study enrollment in women recently treated for breast cancer.
RCT Entities:
OBJECTIVE: Vasomotor symptoms (VMS)(hot flashes, night sweats) are associated with natural or surgically or chemotherapy-induced menopause, the latter occurring frequently in women treated for breast cancer. To manage VMS, some women seek alternatives to menopausal hormone therapy, such as supplements or modified food choices. The objective of the present analyses was to assess associations of VMS occurrence and change in severity of VMS over 12 months with dietary intakes of fiber, fat, and selected soy-containing foods, and use of phytoestrogen or vitamin E supplements in women with recent early stage breast cancer, adjusting for covariates. DESIGN: Using multivariate logistic regression, data were analyzed from 2,198 women with early-stage breast cancer who enrolled 2 to 48 months after diagnosis in the Women's Healthy Eating and Living randomized, controlled trial of a high-vegetable, high-fiber, reduced-fat diet. RESULTS: Being peri- or postmenopausal, using tamoxifen, having low social support or depressive symptoms, and using vitamin E or phytoestrogen supplements were significantly associated cross-sectionally with reporting moderate/severe VMS at enrollment. Increased symptom severity after 12 months was significantly associated with higher body mass index, tamoxifen use, and smoking. Decreased symptom severity at 12 months was significantly associated with high dietary fiber intake; no decrease was observed in women who were peri- or postmenopausal, using tamoxifen, or had low fat intake or low social support. CONCLUSIONS: High dietary fiber intakes, premenopausal, and high social support were related to decreased severity of VMS 1 year after study enrollment in women recently treated for breast cancer.
Authors: Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith Journal: Cochrane Database Syst Rev Date: 2012-05-16
Authors: Ellen B Gold; Katherine Leung; Sybil L Crawford; Mei-Hua Huang; L Elaine Waetjen; Gail A Greendale Journal: Menopause Date: 2013-03 Impact factor: 2.953
Authors: Teresa Lanza di Scalea; Karen A Matthews; Nancy E Avis; Rebecca C Thurston; Charlotte Brown; Sioban Harlow; Joyce T Bromberger Journal: J Womens Health (Larchmt) Date: 2012-02-23 Impact factor: 2.681
Authors: Tsogzolmaa Dorjgochoo; Kai Gu; Ying Zheng; Asha Kallianpur; Zhi Chen; Wei Zheng; Wei Lu; Xiao Ou Shu Journal: Breast Cancer Res Treat Date: 2010-08-12 Impact factor: 4.872
Authors: Candyce H Kroenke; Bette J Caan; Marcia L Stefanick; Garnet Anderson; Robert Brzyski; Karen C Johnson; Erin LeBlanc; Cathy Lee; Andrea Z La Croix; Hannah Lui Park; Stacy T Sims; Mara Vitolins; Robert Wallace Journal: Menopause Date: 2012-09 Impact factor: 2.953
Authors: H Irene Su; Shaylyn Stark; Brian Kwan; Sarah Boles; Diana Chingos; Jennifer Ehren; Jessica R Gorman; Michael Krychman; Sally A D Romero; Jun J Mao; John P Pierce; Loki Natarajan Journal: Breast Cancer Res Treat Date: 2019-05-03 Impact factor: 4.872
Authors: Cheryl L Rock; Shirley W Flatt; Gail A Laughlin; Ellen B Gold; Cynthia A Thomson; Loki Natarajan; Lovell A Jones; Bette J Caan; Marcia L Stefanick; Richard A Hajek; Wael K Al-Delaimy; Frank Z Stanczyk; John P Pierce Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-03-06 Impact factor: 4.254
Authors: Yuan-Yuan Lei; Suzanne C Ho; Ashley Cheng; Carol Kwok; Ka Li Cheung; Yi-Qian He; Roselle Lee; Winnie Yeo Journal: Breast Cancer Res Treat Date: 2020-04-01 Impact factor: 4.872